Back

MicroRNA-21 restrains myD88-dependent protective inflammation worsening Staphylococcus aureus skin infection

Salina, A. C. G.; Blackman, A.; Medeiros, A.; Serezani, C.

2026-06-04 immunology
10.64898/2026.06.01.729375 bioRxiv
Show abstract

Staphylococcus aureus skin infections are driven by tissue-resident and recruited immune cells. A proper immune response requires a tightly regulated balance between inflammatory responses and the prevention of tissue damage. MicroRNAs are key post-transcriptional regulators of immune responses and influence both pro- and anti-inflammatory pathways. We show that S. aureus skin infection elevates miR-21 levels in the skin, and applying a topical miR-21 antagomir improves bacterial clearance and resolution of skin infection. In MRSA-infected mice lacking miR-21 in myeloid cells (miR21{Delta}myel), lesions are smaller, bacterial load decreases, macrophage infiltration is reduced, and collagen around the abscess increases. MiR-21 helps shape the inflammatory environment by modulating mediators such as IL-1{beta}, TNF, IL-33, and IL-10. Additionally, miR-21 deficiency increases MyD88 expression in infected skin, and blocking MyD88 actions abolishes the protective effects observed in miR21{Delta}myel mice. Overall, the miR-21/MyD88 pathway is a key regulator of the resolution of inflammation and antibacterial immunity during S. aureus skin infections, highlighting miR-21 inhibition as a promising therapy for antibiotic-resistant S. aureus infections.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
PLOS Pathogens
820 papers in training set
Top 1%
11.6%
2
Frontiers in Immunology
638 papers in training set
Top 2%
7.1%
3
Nature Communications
5641 papers in training set
Top 24%
6.6%
4
Mucosal Immunology
47 papers in training set
Top 0.2%
6.1%
5
Science Immunology
88 papers in training set
Top 0.5%
5.4%
6
EMBO Molecular Medicine
95 papers in training set
Top 0.1%
4.2%
7
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 14%
3.9%
8
mBio
833 papers in training set
Top 5%
3.9%
9
Journal of Experimental Medicine
119 papers in training set
Top 0.7%
3.4%
50% of probability mass above
10
Cell Reports
1498 papers in training set
Top 13%
3.2%
11
The Journal of Immunology
166 papers in training set
Top 1.0%
3.1%
12
Journal of Clinical Investigation
179 papers in training set
Top 2%
3.1%
13
Science Translational Medicine
127 papers in training set
Top 0.7%
3.1%
14
JCI Insight
277 papers in training set
Top 2%
3.1%
15
eLife
5828 papers in training set
Top 38%
2.7%
16
Disease Models & Mechanisms
20 papers in training set
Top 0.1%
2.4%
17
Cell Death & Disease
21 papers in training set
Top 0.2%
1.7%
18
PLOS ONE
5266 papers in training set
Top 50%
1.6%
19
Scientific Reports
3612 papers in training set
Top 57%
1.6%
20
Journal of Investigative Dermatology
49 papers in training set
Top 0.4%
1.3%
21
EMBO Reports
263 papers in training set
Top 5%
1.3%
22
Journal of Neuroinflammation
61 papers in training set
Top 1%
1.1%
23
Nature Immunology
79 papers in training set
Top 2%
1.0%
24
Annals of the Rheumatic Diseases
36 papers in training set
Top 0.5%
0.8%
25
iScience
1154 papers in training set
Top 36%
0.8%
26
European Journal of Immunology
60 papers in training set
Top 1%
0.8%
27
Infection and Immunity
120 papers in training set
Top 2%
0.8%
28
Journal of Allergy and Clinical Immunology
27 papers in training set
Top 0.6%
0.6%
29
Cell Reports Medicine
153 papers in training set
Top 6%
0.6%
30
Immunity
67 papers in training set
Top 2%
0.6%